Latest Quarterly Report
Filed: 2026-05-01
Key Insights
- Filing appears corrupted or improperly formatted with truncated XBRL taxonomy references and no readable financial statements, making it impossible to assess Q1 2026 performance against prior periods.
- Multiple references to acquisitions (Touchland, TheraBreath, Zicam) and divestitures (Spinbrush, VMS) suggest active portfolio restructuring, though specific financial impacts cannot be determined from this malformed document.
- Complex debt structure evidenced by multiple senior notes at various rates (2.3% to 5.6%) due through 2052 requires clarification on refinancing risks and interest expense trends that should be disclosed in readable format.